Since FAK and FGFR inhibitors used here were effective against L1-decorated exosomal stimulation, and they also were effective against L1 ectodomain stimulation [14], they may be useful as treatments for GBM tumor cells that express, and are stimulated by, L1. The gene discussed is PTK2; the disease is glioblastoma.